Proceedings: Effect of chronic treatment with perazine (Taxilan-R) on the pharmacokinetic behaviour of phenazone in man.
D014150:Antipsychotic Agents / Q000494:pharmacology*; D000983:Antipyrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D010640:Phenothiazines; D010879:Piperazines / Q000494:pharmacology
D014150:Antipsychotic Agents; D010640:Phenothiazines; D010879:Piperazines; D000983:Antipyrine